Exciting news!
There has been some exciting news recently with EpiVax announcing that it has made great strides in developing precision cancer immunotherapies. You can check out one the 'Freshest' articles on them here: https://www.prnewswire.com/news-releases/epivax-oncology-completes-a-1-2m-bridge-financing-300665275.html Amaz